Company intelligence / Profile preview

Zhejiang Cuize Pharmaceutical Technology

Hangzhou, Zhejiang, Chinaxjpharma.com ↗

Ownership: Private
Development stage: Other

Overview

Zhejiang Cuize Pharmaceutical Technology is a high-tech pharmaceutical R&D company specializing in respiratory medicine technology and complex preparation medicine technology. Its lead asset CZ1S is a small molecule drug currently in Phase 2 clinical trials targeting postoperative pain management after hemorrhoidectomy. The company focuses on developing innovative inhalation preparations and complex formulations with an emphasis on unmet needs in pain management and related therapeutic areas. No published late-stage or commercial results are available.

Therapeutic areas: GastroenterologyNeurology
Modalities: Small molecule drug
Industry: Biotech

Drug pipeline

4 assets

CZ1S

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Zhejiang Cuize Pharmaceutical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Cuize Pharmaceutical Technology.

Explore the full profile